EI-001

· Elixiron Immunotherapeutics (Hong Kong) Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EI-001, covering 2025-06-24 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients [Phase 2]